Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Over reaction much!

View:

Post by ORTsnort on Feb 10, 2020 7:40pm

Over reaction much!

Clearly states first half of 2020 fda Ryplazim resubmission.

they are fast tracked and will most likely have approval in in 2020 but to be safe they state that 2021 is launched out after APPROVAL and run away with $$$$$ flow crazy. They have set the table nicely and it should be an interesting 2020 .

Comment

Comment by realstocky on Feb 10, 2020 10:32pm

This post has been removed in accordance with Community Policy

Comment by marcjohnson on Feb 10, 2020 10:40pm

This post has been removed in accordance with Community Policy

Comment by GoBBs on Feb 10, 2020 10:47pm

your guessing ..you know nothing for fact. fact ryplazim approval 2021 according to the company IF they don't push it back yet again.

Comment

Comment by marcjohnson on Feb 10, 2020 10:49pm

This post has been removed in accordance with Community Policy

Comment by GoBBs on Feb 10, 2020 11:00pm

and your a PAID pumper newcamo/markjohnson/realstocky/pandorum and god know how many other aliases you have ...PAID pumper PAID to pump bs and mislead people. Right ?

Comment

Liminal BioSciences Inc.